Dartmouth-Hitchcock Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Dartmouth-Hitchcock Medical Center sits in the top decile of US sponsors by registered trial count (#85 of 15,742 sponsors by registered trial count).
Dartmouth-Hitchcock Medical Center: 427 sponsored US clinical trials, 52 recruiting.
Dartmouth-Hitchcock Medical Center sponsors 427 registered US clinical trials on ClinicalTrials.gov, 52 of them currently recruiting, and 300 completed. 25 of these trials are in Phase 3-4 (later-stage) and 84 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 12 trials.
Top-decile sponsor footprint
Dartmouth-Hitchcock Medical Center ranks in the top decile of sponsors by registered trial count (#85 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
300 of 352 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
427 total, page 2 of 9
Comparative Effectiveness of IIMR Versus CDSMP
NCT03966872
Internet Based Psychological Support
NCT02726061
HOBSCOTCH for People With Post Acute COVID-19 Syndrome (PACS)
NCT06391489
Improving Care, Accelerating Recovery and Education
NCT06233747
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's)
NCT06260228
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS)
NCT06145737
Reduced-dose Botox for Urgency Incontinence Among Elder Females
NCT05512039
Maximizing Patient Goal Attainment
NCT05652270
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) -Post-Traumatic Epilepsy (PTE)
NCT05235061
Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)
NCT04568616
ICG Fluorescence Imaging in Open Fracture Trauma Patients
NCT04416412
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
NCT03480360
Magnetic Resonance Elastography in Hydrocephalus
NCT02230124
The Agenda-Setting for Kidney Disease Trial
NCT07024953
Influence of Lidocaine Infusion on Motor Evoked Potential Thresholds
NCT06792474
Measurement of Osteoarthritic Patient Pain Through Electrodermal Activity Signals
NCT06701461
In Vivo Imaging of the Olfactory Epithelium Using Confocal Laser Endomicroscopy
NCT07546617
The Agenda-Setting for Kidney Disease Open Pilot Trial
NCT07221604
aPBI Re-irradiation
NCT07612254
Plan and Protect: Safety Planning for Teens in Rural Emergency Departments
NCT07325474
Epileptiform Potential of Fully Immersive Virtual Reality
NCT07451093
ASKids! Inpatient Agenda-Setting Study for Hospitalized Children With Medical Complexity
NCT07127666
Flush, Lyse, Operate
NCT07592520
Psychosocial Skills Group for Pelvic Floor Symptoms
NCT07429539
Remote Evaluation and Alerting for Collaborative Health (REACH) in Depression
NCT07174557
Implementation Intention Planning Guide for FIT Colon Cancer Screening
NCT07183046
The Effect of Essential Oil Inhalation Patches on Perceived Burn-out & Stress on an Inpatient Medical-surgery Unit.
NCT06053450
Positive Psychology for Smoking Cessation
NCT06632756
Chatbot for Depression, Anxiety, and Eating Disorders
NCT06013137
Dietary Impact on Continuous Glucose Monitoring
NCT05845827
An Observational Pilot Study to Test a Smartwatch-based EMA Method During Exercise With Breast Cancer Survivors
NCT05868746
NIRST and ICG-based Perfusion Imaging in Acute Compartment Syndrome
NCT05672381
Connect ME: Improving Social Connectedness
NCT05686681
Non Invasive Continuous Blood Pressure Sensor
NCT05689294
Fiber Supplementation After Bariatric Surgery
NCT05653648
The Science of the Art of Palliative Care
NCT05137782
Trauma Study: Early Warning of Progression Toward Hemodynamic Deterioration After Trauma
NCT04912232
Multicenter Sous Vide Frostbite
NCT05280301
Portable Measurement of Protoporphyrin IX in the Skin
NCT04223570
Exercise and Oxaliplatin-induced Peripheral Neuropathy
NCT05916118
Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment
NCT05411315
Managing Challenging Behaviors-ADHD
NCT05674968
S-Asenosyl-L-Methionine vs Placebo for Osteoarthritis of the Hands
NCT05363020
SFDI in High Energy Lower Extremity Fracture
NCT05635617
Antibiotic Concentration After Delivery to Middle Ear for Chronic Suppurative Otitis Media
NCT05133258
Study of Structural and Functional Brain Connectivity Changes in ALS (CoALS-II)
NCT05404867
Study of Forceps Cannulation During ERCP
NCT05336630
High-fat Meal Challenge in Pediatrics
NCT05230433
Measuring the Effectiveness of Self-Care Sampler for Family Care Partners in Reducing Caregiver Stress
NCT05390333
Modulation of Emotion Perception in Humans Via Amygdala Stimulation
NCT05292183
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 44 |
| Phase 2 | 40 |
| Phase 3 | 6 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the Dartmouth-Hitchcock Medical Center pipeline
52 recruiting of 427 indexed (12% open); 300 completed (70%).
Phase mix: 25 late (III/IV) vs 84 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Dartmouth-Hitchcock Medical Center: open-pipeline peers nationwide
Peers matched on 427 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Dartmouth-Hitchcock Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 427 trials (± recruiting share)
- University of Illinois at Chicago · 430 trials · 27% recruiting
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Friends Research Institute · 12% recruiting · 41 trials
- Antonios Likourezos · 12% recruiting · 33 trials
- Oregon State University · 12% recruiting · 33 trials
- University of Massachusetts, Amherst · 12% recruiting · 33 trials
Related
What to do with this Dartmouth-Hitchcock Medical Center page
427 registered trials is a research-attention snapshot, not an endorsement of Dartmouth-Hitchcock Medical Center or any single study.
- 52 of Dartmouth-Hitchcock Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Dartmouth-Hitchcock Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Dartmouth-Hitchcock Medical Center pipeline card: 427 registered trials from official public datasets.Report a data error.